Last reviewed · How we verify

NCT06871241

Public Awareness and Understanding of PC in the UAE

Completed Last updated 11 March 2025
What this trial tests

trial in Palliative Care in 824 participants. Completed in 15 January 2025.

Timeline
25 July 2024
Primary endpoint
18 August 2024
15 January 2025

Quick facts

Lead sponsorBurjeel Medical City
StatusCompleted
Study typeOBSERVATIONAL
Enrollment824
Start date25 July 2024
Primary completion18 August 2024
Estimated completion15 January 2025
Sites1 location across United Arab Emirates

Conditions studied

Sponsor

Burjeel Medical City

Who can join

14 and older, any sex, with Palliative Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Palliative care (PC) is essential medical care for improving the quality of life for patients with life-threatening illnesses and their families. There has been substantial evolution of PC services in the United Arab Emirates (UAE), yet public awareness regarding PC remains shallow, hindering its utilization and acceptance on a large scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing